Thalassaemia Trait and Intermedia
On this page
Direct answer
Thalassaemia trait is a carrier state with microcytosis and mild or no anaemia, arising from one defective globin gene. Thalassaemia intermedia describes moderate anaemia that usually does not need regular transfusion and sits between trait and major disease. The Mentzer index helps separate the trait from iron deficiency, while the globin genotype predicts clinical severity.
What you must remember
- Trait: heterozygous carriers have microcytosis with mild or no anaemia, and most are clinically well.
- Mentzer index: MCV divided by the red cell count in millions per microlitre; below 13 suggests thalassaemia trait, and above 13 suggests iron deficiency.
- Normal ferritin: thalassaemia trait keeps iron stores normal, whereas iron deficiency lowers ferritin, which is a key differentiator.
- Intermedia: moderate anaemia, often around 7 to 10 g/dL, with transfusion needed only occasionally, though splenomegaly and bony changes may occur.
- Genotype-phenotype: beta zero homozygotes have transfusion-dependent major disease, while beta plus variants are often milder.
- Hydroxyurea: raises fetal haemoglobin in selected intermedia patients and can reduce transfusion need.
- Alpha trait: loss of two alpha genes gives microcytosis with normal HbA2, and silent carriers with one lost gene may be missed without genotyping.
Where the exam tries to catch you
Thalassaemia questions often hinge on whether the microcytosis is genetic or iron-related.
- Trap: diagnosing trait from microcytosis without measuring ferritin or the Mentzer index Correct: iron deficiency mimics trait, and the index with ferritin separates the two.
- Trap: starting iron supplements in thalassaemia trait Correct: iron is not indicated, since extra iron accumulates and worsens overload.
- Trap: assuming intermedia is transfusion-free for life Correct: infection, pregnancy or a fall in haemoglobin can create a transfusion need.
- Trap: assuming genotype does not affect severity Correct: beta zero homozygotes are severe, whereas beta plus variants are often milder.
Frequently asked questions
How is the Mentzer index used to separate thalassaemia trait from iron deficiency?
The Mentzer index is the MCV divided by the red blood cell count in millions per microlitre. A value below 13 suggests thalassaemia trait, while a value above 13 suggests iron deficiency. It is a screening aid, and haemoglobin electrophoresis remains the confirmatory test.
Why is iron supplementation not given in thalassaemia trait?
Iron stores in thalassaemia trait are normal or raised, so iron supplementation is not indicated. Extra iron can accumulate and worsen overload in people who already absorb iron more efficiently. A normal serum ferritin supports this decision.
What is the key difference between thalassaemia intermedia and major?
Thalassaemia intermedia causes moderate anaemia that usually does not need regular transfusion, while major is transfusion-dependent from early childhood. Intermedia can still cause splenomegaly, bony changes and iron overload, so monitoring is required. The globin genotype largely determines which pattern develops.
How does hydroxyurea help patients with thalassaemia intermedia?
Hydroxyurea raises fetal haemoglobin production, which partly compensates for the globin chain imbalance and can lift haemoglobin. In selected intermedia patients it reduces transfusion needs. Its use requires careful blood count monitoring and specialist supervision.
Why does the beta globin genotype determine severity in thalassaemia?
Beta zero mutations produce no beta globin chain, causing severe disease in homozygotes, while beta plus mutations allow some production and milder disease. Compound heterozygotes and HbE/beta thalassaemia lie between these extremes. The genotype therefore predicts transfusion need and the likely clinical course.